Tilray Brands (TLRY) Interest Expenses (2017 - 2026)
Tilray Brands' (TLRY) quarterly Interest Expenses came in at $26.0 million in Q2 2026, down 25.74% YoY from $35.0 million in Q2 2025, and down 68.11% on a QoQ basis from $81.5 million in Q1 2026.
Tilray Brands (TLRY) Interest Expenses (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Interest Expenses data on file, last reported at $26.0 million in Q2 2026.
- Quarterly Interest Expenses fell 25.74% year-over-year to $26.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $140.0 million (up 19.23% YoY) and the FY2026 annual result came in at $997.4 million, up 2.93% from the prior year.
- Interest Expenses eased to $26.0 million in Q2 2026, from $81.5 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $354.1 million in Q2 2022 to a low of $2.9 million in Q3 2025.
- A 5-year average of $70.1 million and a median of $72.1 million in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses soared 2057.33% — and 2025, when it slumped 96.11%.
- Tracing TLRY's Interest Expenses over 5 years: stood at $59.2 million in 2022, then gained by 24.52% to $73.7 million in 2023, then decreased by 1.47% to $72.6 million in 2024, then increased by 13.56% to $82.5 million in 2025, then tumbled by 68.49% to $26.0 million in 2026.
- The last three Interest Expenses figures came in at $26.0 million (Q2 2026), $81.5 million (Q1 2026), and $82.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Tilray Brands | 516.53 Mn | 281.90 Mn | 90.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 25.99 Mn |
| May 31, 2026 | 25.99 Mn |
| Feb 28, 2026 | 81.49 Mn |
| Feb 28, 2026 | 81.49 Mn |
| Nov 30, 2025 | 82.49 Mn |
| Nov 30, 2025 | 82.49 Mn |
| Aug 31, 2025 | 2.90 Mn |
| Aug 31, 2025 | 2.90 Mn |
| May 31, 2025 | 35.00 Mn |
| May 31, 2025 | 35.00 Mn |
| Feb 28, 2025 | 71.52 Mn |
| Feb 28, 2025 | 71.52 Mn |
| Nov 30, 2024 | 72.64 Mn |
| Nov 30, 2024 | 72.64 Mn |
| Aug 31, 2024 | 74.43 Mn |
| Aug 31, 2024 | 74.43 Mn |
| May 31, 2024 | 42.54 Mn |
| May 31, 2024 | 42.54 Mn |
| Feb 29, 2024 | 73.44 Mn |
| Feb 29, 2024 | 73.44 Mn |